pregnanolone has been researched along with Diabetic Neuropathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbasnejad, M; Afrazi, S; Esmaeili-Mahani, S; Sheibani, V | 1 |
| Bianchi, R; Caruso, D; Cavaletti, G; Crippa, D; Garcia-Segura, LM; Lauria, G; Leonelli, E; Magnaghi, V; Melcangi, RC; Roglio, I | 1 |
2 other study(ies) available for pregnanolone and Diabetic Neuropathies
| Article | Year |
|---|---|
Neurosteroid allopregnanolone attenuates high glucose-induced apoptosis and prevents experimental diabetic neuropathic pain: in vitro and in vivo studies.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Survival; Cytoprotection; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Glucose; Male; Nociception; PC12 Cells; Pregnanolone; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Spinal Cord | 2014 |
Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis.
Topics: 20-alpha-Dihydroprogesterone; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Down-Regulation; Male; Myelin Proteins; Neural Conduction; Neuroprotective Agents; Pain Threshold; Peripheral Nerves; Pregnanolone; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Recovery of Function; RNA, Messenger; Sensory Receptor Cells; Skin; Sodium-Potassium-Exchanging ATPase; Treatment Outcome | 2007 |